Clinical Trial Update: Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis [NA]

View source ↗

Summary

A clinical trial is evaluating intrastromal moxifloxacin as an adjunctive therapy for recalcitrant bacterial keratitis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Keratitis
• Corneal Ulcer
• Recalcitrant Infectious Keratitis

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Minia University | Conditions: Bacterial Keratitis, Recalcitrant Infectious Keratitis | NA | Status: RECRUITING